Clinical Trial

Study of Secutrelvir in Participants With COVID-19

Name: Study of Secutrelvir in Participants With COVID-19 — clinical trial record (NCT07746544)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to compare secutrelvir to placebo with respect to resolution of clinical symptoms in nonhospitalized participants with Coronavirus Disease 2019 (COVID-19) starting intervention within 48 hours of COVID-19 symptom onset.

Trial Details

NCT Number	NCT07746544
Lead Sponsor	Shionogi
Conditions	COVID-19
Enrollment	1,200 participants
Start Date	2026-07-20
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-05